Rockwell Medical (RMTI) Reports Q2 Loss, Tops Revenue Estimates

Rockwell Medical (RMTI) came out with a quarterly loss of $0.05 per share in line with the Zacks Consensus Estimate. This compares to earnings of $0.01 per share a year ago. These figures are adjusted for non-recurring items. A quarter ago, it was expected that this maker of products used in the treatment of kidney disease and anemia would post a loss of $0.03 per share when it actually produced a loss of $0.04, delivering a surprise of -33.33%.Over the last four quarters, the company has surpassed consensu ...